Semler Scientific, Inc. (SMLR)
USD 34.06
(-8.02%)
USD 34.06
(-8.02%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 23.58 Million USD | 25.09% |
| 2022 | 17.79 Million USD | -8.5% |
| 2021 | 19.44 Million USD | 21.83% |
| 2020 | 15.96 Million USD | 49.15% |
| 2019 | 11.34 Million USD | 100.47% |
| 2018 | 5.84 Million USD | 715.69% |
| 2017 | -487 Thousand USD | 59.84% |
| 2016 | -1.71 Million USD | 74.36% |
| 2015 | -8.1 Million USD | -93.99% |
| 2014 | -4.14 Million USD | -117.43% |
| 2013 | -1.99 Million USD | 21.66% |
| 2012 | -2.54 Million USD | -42.75% |
| 2011 | -1.78 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 7.12 Million USD | 147.64% |
| 2024 Q3 | 5.06 Million USD | -5.33% |
| 2024 Q2 | 5.54 Million USD | -23.31% |
| 2023 Q2 | 7.44 Million USD | 14.62% |
| 2023 Q1 | 6.49 Million USD | 73.44% |
| 2023 FY | - USD | 25.09% |
| 2023 Q4 | 2.52 Million USD | -59.96% |
| 2023 Q3 | 6.29 Million USD | -15.35% |
| 2022 Q3 | 4.62 Million USD | -13.35% |
| 2022 Q4 | 3.74 Million USD | -18.98% |
| 2022 Q1 | 3.94 Million USD | 130.53% |
| 2022 FY | - USD | -8.5% |
| 2022 Q2 | 5.33 Million USD | 35.26% |
| 2021 Q1 | 6.01 Million USD | 0.4% |
| 2021 Q4 | 1.71 Million USD | -67.45% |
| 2021 Q2 | 6.46 Million USD | 7.39% |
| 2021 FY | - USD | 21.83% |
| 2021 Q3 | 5.25 Million USD | -18.73% |
| 2020 Q1 | 3.45 Million USD | 13.33% |
| 2020 Q2 | 960 Thousand USD | -72.19% |
| 2020 Q4 | 5.99 Million USD | 4.59% |
| 2020 FY | - USD | 49.15% |
| 2020 Q3 | 5.73 Million USD | 497.08% |
| 2019 Q3 | 3.11 Million USD | 15.36% |
| 2019 Q2 | 2.69 Million USD | 45.42% |
| 2019 Q4 | 3.04 Million USD | -2.06% |
| 2019 Q1 | 1.85 Million USD | 28.13% |
| 2019 FY | - USD | 100.47% |
| 2018 FY | - USD | 715.69% |
| 2018 Q4 | 1.44 Million USD | -6.22% |
| 2018 Q3 | 1.54 Million USD | 0.59% |
| 2018 Q2 | 1.53 Million USD | 64.42% |
| 2018 Q1 | 933 Thousand USD | 151.48% |
| 2017 Q1 | -621 Thousand USD | -502.91% |
| 2017 Q2 | -735 Thousand USD | -18.36% |
| 2017 Q3 | 76 Thousand USD | 110.34% |
| 2017 Q4 | 371 Thousand USD | 388.16% |
| 2017 FY | - USD | 59.84% |
| 2016 Q1 | -932 Thousand USD | 77.84% |
| 2016 FY | - USD | 74.36% |
| 2016 Q4 | -103 Thousand USD | 59.61% |
| 2016 Q3 | -255 Thousand USD | 70.69% |
| 2016 Q2 | -870 Thousand USD | 6.65% |
| 2015 Q4 | -4.2 Million USD | -171.01% |
| 2015 Q3 | -1.55 Million USD | -18.2% |
| 2015 FY | - USD | -93.99% |
| 2015 Q2 | -1.31 Million USD | 2.6% |
| 2015 Q1 | -1.34 Million USD | -14.53% |
| 2014 Q1 | -744 Thousand USD | -68.71% |
| 2014 Q3 | -1.31 Million USD | -37.01% |
| 2014 Q4 | -1.17 Million USD | 10.7% |
| 2014 FY | - USD | -117.43% |
| 2014 Q2 | -962 Thousand USD | -29.3% |
| 2013 Q4 | -441 Thousand USD | 9.26% |
| 2013 Q1 | -514 Thousand USD | 15.46% |
| 2013 FY | - USD | 21.66% |
| 2013 Q2 | -565 Thousand USD | -9.92% |
| 2013 Q3 | -486 Thousand USD | 13.98% |
| 2012 Q3 | -625 Thousand USD | 0.0% |
| 2012 Q4 | -608 Thousand USD | 2.72% |
| 2012 FY | - USD | -42.75% |
| 2011 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 274.902% |
| Cerus Corporation | -26.53 Million USD | 188.894% |
| OrthoPediatrics Corp. | -8.38 Million USD | 381.458% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 324.775% |
| Talis Biomedical Corporation | -66.04 Million USD | 135.717% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 241.463% |
| Inogen, Inc. | -45.67 Million USD | 151.641% |
| Spectral AI, Inc. | -12.26 Million USD | 292.375% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 149.46% |
| CVRx, Inc. | -38.73 Million USD | 160.905% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 768.622% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 294.838% |
| Orthofix Medical Inc. | -86.98 Million USD | 127.118% |
| Venus Concept Inc. | -26.11 Million USD | 190.334% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 147.395% |
| Bioventus Inc. | -23.07 Million USD | 202.25% |
| BrainsWay Ltd. | -2.31 Million USD | 1120.727% |
| Envoy Medical, Inc. | -18.23 Million USD | 229.34% |
| electroCore, Inc. | -17.76 Million USD | 232.821% |
| IceCure Medical Ltd | -15.25 Million USD | 254.652% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 147.414% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 239.947% |
| MaxCyte, Inc. | -44.12 Million USD | 153.456% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 300.655% |
| Nexalin Technology, Inc. | -5.69 Million USD | 514.421% |
| PAVmed Inc | -75.74 Million USD | 131.144% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 143.88% |
| RxSight, Inc. | -41.03 Million USD | 157.482% |
| Sight Sciences, Inc. | -49.41 Million USD | 147.737% |
| SI-BONE, Inc. | -34.44 Million USD | 168.481% |
| TELA Bio, Inc. | -40.63 Million USD | 158.054% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 140.463% |
| Treace Medical Concepts, Inc. | -39 Million USD | 160.472% |
| LivaNova PLC | 39.01 Million USD | 39.54% |
| 908 Devices Inc. | -34.02 Million USD | 169.328% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 121.33% |
| Nemaura Medical Inc. | -7.28 Million USD | 423.711% |
| NeuroPace, Inc. | -22.83 Million USD | 203.306% |
| LENSAR, Inc. | -8.71 Million USD | 370.702% |
| Apyx Medical Corporation | -18.11 Million USD | 230.24% |
| Cutera, Inc. | -136.56 Million USD | 117.274% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 797.899% |
| BioSig Technologies, Inc. | -28.15 Million USD | 183.795% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -837.56% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 212.387% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 93.85% |
| Axonics, Inc. | 7.77 Million USD | -203.395% |
| Outset Medical, Inc. | -153.78 Million USD | 115.339% |
| IRIDEX Corporation | -7.44 Million USD | 416.716% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 124.047% |
| IRadimed Corporation | 20.8 Million USD | -13.405% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 392.595% |
| INVO Bioscience, Inc. | -6.88 Million USD | 442.862% |
| Telesis Bio, Inc. | -40.49 Million USD | 158.255% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 35.684% |
| Varex Imaging Corporation | 67.2 Million USD | 64.897% |
| Quipt Home Medical Corp. | 44.07 Million USD | 46.475% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 317.01% |
| Pulmonx Corporation | -55.09 Million USD | 142.817% |
| Dynatronics Corporation | -976 Thousand USD | 2516.886% |
| Modular Medical, Inc. | -17.1 Million USD | 237.923% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 262.851% |
| InMode Ltd. | 196.28 Million USD | 87.982% |
| Bruker Corporation | 599 Million USD | 96.062% |
| Cytosorbents Corporation | -28.81 Million USD | 181.875% |
| DexCom, Inc. | 916.7 Million USD | 97.427% |
| Align Technology, Inc. | 799.03 Million USD | 97.048% |
| Viveve Medical, Inc. | -20.61 Million USD | 214.415% |
| ZimVie Inc. | 91.07 Million USD | 74.099% |
| Movano Inc. | -29.12 Million USD | 180.992% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 635.141% |
| Nexalin Technology, Inc. | -5.69 Million USD | 514.421% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 768.622% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 112.118% |
| Profound Medical Corp. | -27.12 Million USD | 186.969% |
| Insulet Corporation | 323.6 Million USD | 92.71% |
| enVVeno Medical Corporation | -25.01 Million USD | 194.288% |
| Surmodics, Inc. | 1.18 Million USD | -1885.606% |
| iCAD, Inc. | -6.56 Million USD | 459.315% |
| Nuwellis, Inc. | -16.35 Million USD | 244.222% |
| Biotricity, Inc. | -8.82 Million USD | 367.198% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 124.353% |
| Aethlon Medical, Inc. | -11.84 Million USD | 299.078% |
| InspireMD, Inc. | -20.91 Million USD | 212.807% |
| PAVmed Inc. | -75.74 Million USD | 131.144% |
| BIOLASE, Inc. | -15.13 Million USD | 255.816% |
| Beyond Air, Inc. | -59.03 Million USD | 139.96% |
| FONAR Corporation | 28.25 Million USD | 16.504% |
| AxoGen, Inc. | -13.32 Million USD | 276.988% |
| Vivani Medical, Inc. | -26.6 Million USD | 188.654% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 3.879% |
| Inari Medical, Inc. | 7.11 Million USD | -231.632% |
| UFP Technologies, Inc. | 72.74 Million USD | 67.572% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 796.707% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 483.187% |
| Tenon Medical, Inc. | -15.52 Million USD | 251.913% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 254.52% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 156.874% |
| AdaptHealth Corp. | -171.09 Million USD | 113.787% |
| Sintx Technologies, Inc. | -6.6 Million USD | 457.409% |
| NanoVibronix, Inc. | -3.43 Million USD | 786.725% |
| Quanterix Corporation | -38.08 Million USD | 161.933% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 317.01% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -78530.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 108.507% |
| TransMedics Group, Inc. | -7.6 Million USD | 410.259% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 208.38% |
| NeuroMetrix, Inc. | -7.09 Million USD | 432.436% |
| Hyperfine, Inc. | -47.06 Million USD | 150.124% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 140.457% |
| Biomerica, Inc. | -5.99 Million USD | 493.609% |
| Bone Biologics Corporation | 479.57 Thousand USD | -4818.761% |
| AVITA Medical, Inc. | -39.56 Million USD | 159.617% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 357.159% |
| Silk Road Medical, Inc | -45.08 Million USD | 152.327% |